204 related articles for article (PubMed ID: 29538406)
1. Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection.
Di Poto C; He S; Varghese RS; Zhao Y; Ferrarini A; Su S; Karabala A; Redi M; Mamo H; Rangnekar AS; Fishbein TM; Kroemer AH; Tadesse MG; Roy R; Sherif ZA; Kumar D; Ressom HW
PLoS One; 2018; 13(3):e0192748. PubMed ID: 29538406
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in the progression to cirrhosis and hepatocellular carcinoma in HCV-infected veterans.
El-Serag HB; Kramer J; Duan Z; Kanwal F
Am J Gastroenterol; 2014 Sep; 109(9):1427-35. PubMed ID: 25070058
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C-positive Black patients develop hepatocellular carcinoma at earlier stages of liver disease and present with a more aggressive phenotype.
Shaltiel T; Zheng S; Siderides C; Gleeson EM; Carr J; Pletcher ER; Cohen NA; Golas BJ; Magge DR; Labow DM; Branch AD; Sarpel U
Cancer; 2021 May; 127(9):1395-1406. PubMed ID: 33629759
[TBL] [Abstract][Full Text] [Related]
4. Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis.
Nguyen MH; Garcia RT; Simpson PW; Wright TL; Keeffe EB
Hepatology; 2002 Aug; 36(2):410-7. PubMed ID: 12143050
[TBL] [Abstract][Full Text] [Related]
5. Metabolomic Characterization of Hepatocellular Carcinoma in Patients with Liver Cirrhosis for Biomarker Discovery.
Di Poto C; Ferrarini A; Zhao Y; Varghese RS; Tu C; Zuo Y; Wang M; Nezami Ranjbar MR; Luo Y; Zhang C; Desai CS; Shetty K; Tadesse MG; Ressom HW
Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):675-683. PubMed ID: 27913395
[No Abstract] [Full Text] [Related]
6. Proteomic analysis of HCV cirrhosis and HCV-induced HCC: identifying biomarkers for monitoring HCV-cirrhotic patients awaiting liver transplantation.
Mas VR; Maluf DG; Archer KJ; Yanek K; Bornstein K; Fisher RA
Transplantation; 2009 Jan; 87(1):143-52. PubMed ID: 19136905
[TBL] [Abstract][Full Text] [Related]
7. Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity.
Dillon ST; Bhasin MK; Feng X; Koh DW; Daoud SS
J Transl Med; 2013 Oct; 11():239. PubMed ID: 24283668
[TBL] [Abstract][Full Text] [Related]
8. Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase.
Yang JD; Dai J; Singal AG; Gopal P; Addissie BD; Nguyen MH; Befeler AS; Reddy KR; Schwartz M; Harnois DM; Yamada H; Gores GJ; Feng Z; Marrero JA; Roberts LR
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1085-1092. PubMed ID: 28258053
[No Abstract] [Full Text] [Related]
9. Cytotoxic T Cell Expression of Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) in Viral Hepatitis C-Mediated Hepatocellular Carcinoma.
Hammad R; Aglan RB; Mohammed SA; Awad EA; Elsaid MA; Bedair HM; Khirala SK; Selim MA; Abo Elqasem AA; Rushdi A; Ali M; Abo-Elkheir OI; Sanad EF; Hamdy NM
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293412
[TBL] [Abstract][Full Text] [Related]
10. Histological versus clinical cirrhosis in chronic hepatitis C: does race/ethnicity really matter?
Kohla M; Iwata S; Ea R; Keyhan S; Taylor R; Yu MC; Groshen S; Bonacini M
Dig Dis Sci; 2012 Mar; 57(3):771-6. PubMed ID: 21948357
[TBL] [Abstract][Full Text] [Related]
11. Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.
Koskinas J; Petraki K; Kavantzas N; Rapti I; Kountouras D; Hadziyannis S
J Viral Hepat; 2005 Nov; 12(6):635-41. PubMed ID: 16255765
[TBL] [Abstract][Full Text] [Related]
12. Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.
Tunissiolli NM; Castanhole-Nunes MMU; Pavarino ÉC; da Silva RF; da Silva RCMA; Maria Goloni-Bertollo E
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2795-2802. PubMed ID: 30360608
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of metabolite biomarkers for hepatocellular carcinoma through stratified analysis by gender, race, and alcoholic cirrhosis.
Xiao J; Zhao Y; Varghese RS; Zhou B; Di Poto C; Zhang L; Tadesse MG; Ziada DH; Shetty K; Ressom HW
Cancer Epidemiol Biomarkers Prev; 2014 Jan; 23(1):64-72. PubMed ID: 24186894
[TBL] [Abstract][Full Text] [Related]
14. Latent hepatitis B is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C.
Reddy A; May E; Ehrinpreis M; Mutchnick M
World J Gastroenterol; 2013 Dec; 19(48):9328-33. PubMed ID: 24409059
[TBL] [Abstract][Full Text] [Related]
15. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
16. Risk of hepatobiliary disease in adults with severe alpha 1-antitrypsin deficiency (PiZZ): is chronic viral hepatitis B or C an additional risk factor for cirrhosis and hepatocellular carcinoma?
Elzouki AN; Eriksson S
Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):989-94. PubMed ID: 8930564
[TBL] [Abstract][Full Text] [Related]
17. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
[TBL] [Abstract][Full Text] [Related]
18. Higher risk of hepatocellular carcinoma in Hispanic patients with hepatitis C cirrhosis and metabolic risk factors.
Wong A; Le A; Lee MH; Lin YJ; Nguyen P; Trinh S; Dang H; Nguyen MH
Sci Rep; 2018 May; 8(1):7164. PubMed ID: 29740031
[TBL] [Abstract][Full Text] [Related]
19. Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver.
Cho HJ; Kim B; Lee JD; Kang DR; Kim JK; Lee JH; Shin SJ; Lee KM; Yoo BM; Lee KJ; Kim SS; Cheong JY; Cho SW
Am J Gastroenterol; 2017 Mar; 112(3):460-470. PubMed ID: 27779194
[TBL] [Abstract][Full Text] [Related]
20. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
